Company / Shares Outstanding
Serina Therapeutics, Inc. Shares Outstanding History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
8.4M
FY2025
5-year range
1.1M / 37.9M
FY2021-FY2025
Trend
+249.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shares Outstanding changed +249% YoY in FY2025, a notable deviation from the 6-year average annual change of +48%.
Based on SEC 10-K filings.
8413889.00 in FY2025 with a 5-year CAGR of -25.9%.
Increased from 1079000.00 to 8413889.00 over the past 2 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- -39.5%
- 5-Year CAGR
- -25.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, shares outstanding increased 249.1% year-over-year.
- Peak shares outstanding was recorded in FY2022.
- Lowest shares outstanding in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -18.20 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 8.4M | +249.1% |
| FY2024 | 2.4M | +123.4% |
| FY2023 | 1.1M | -97.2% |
| FY2022 | 37.9M | +0.7% |
| FY2021 | 37.7M | +0.1% |
| FY2020 | 37.6M | +11.6% |
| FY2018 | 33.8M | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026